Tonia Poteat1,2, Andrea Wirtz1, Mannat Malik1, Erin Cooney1, Christopher Cannon3, W David Hardy3,4, Renata Arrington-Sanders5, Maren Lujan6, Thespina Yamanis6. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 2. Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. 3. Research Department, Whitman-Walker Health, Washington, DC. 4. Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, MD. 5. Division of Pediatrics and Adolescent Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 6. American University, School of International Service, Washington, DC.
Abstract
BACKGROUND: Black and Latina transgender women (BLTW) face significant HIV disparities with estimated HIV prevalence up to 50% and annual incidence rates as high as 2.8 per 100 person-years. However, few studies have evaluated the acceptability and uptake of high-impact HIV prevention interventions among BLTW. SETTING: Data collection took place in Baltimore, MD and Washington, DC from May 2015 to May 2017. METHODS: This mixed methods study included quantitative interviewer-administered surveys, key informant interviews, and focus group discussions. Rapid HIV testing followed each survey. Logistic regression models tested associations between legal gender affirmation (ie, desired name and gender marker on identity documents), transgender pride, history of exchange sex, HIV risk perception, and willingness to take pre-exposure prophylaxis (PrEP). Transcripts of qualitative data were coded to identify common themes related to engagement in HIV prevention. RESULTS: Among 201 BLTW, 56% tested HIV-positive and 87% had heard of PrEP. Only 18% who had heard of PrEP had ever taken it. Of the 72 self-reported HIV-negative or status-unknown BLTW who had never taken PrEP, 75% were willing to take it. In multivariable analyses, history of exchange sex was associated with willingness to take PrEP, whereas greater HIV knowledge and transgender pride were associated with lower likelihood of willingness to take PrEP. Concern about drug interactions with hormone therapy was the most frequently reported barrier to PrEP uptake. CONCLUSIONS: Noting the disconnect between PrEP willingness and uptake among BLTW, HIV prevention programs could bridge this gap by responding to identified access barriers and incorporating community-derived strategies.
BACKGROUND: Black and Latina transgender women (BLTW) face significant HIV disparities with estimated HIV prevalence up to 50% and annual incidence rates as high as 2.8 per 100 person-years. However, few studies have evaluated the acceptability and uptake of high-impact HIV prevention interventions among BLTW. SETTING: Data collection took place in Baltimore, MD and Washington, DC from May 2015 to May 2017. METHODS: This mixed methods study included quantitative interviewer-administered surveys, key informant interviews, and focus group discussions. Rapid HIV testing followed each survey. Logistic regression models tested associations between legal gender affirmation (ie, desired name and gender marker on identity documents), transgender pride, history of exchange sex, HIV risk perception, and willingness to take pre-exposure prophylaxis (PrEP). Transcripts of qualitative data were coded to identify common themes related to engagement in HIV prevention. RESULTS: Among 201 BLTW, 56% tested HIV-positive and 87% had heard of PrEP. Only 18% who had heard of PrEP had ever taken it. Of the 72 self-reported HIV-negative or status-unknown BLTW who had never taken PrEP, 75% were willing to take it. In multivariable analyses, history of exchange sex was associated with willingness to take PrEP, whereas greater HIV knowledge and transgender pride were associated with lower likelihood of willingness to take PrEP. Concern about drug interactions with hormone therapy was the most frequently reported barrier to PrEP uptake. CONCLUSIONS: Noting the disconnect between PrEP willingness and uptake among BLTW, HIV prevention programs could bridge this gap by responding to identified access barriers and incorporating community-derived strategies.
Authors: Erik D Storholm; Wenjing Huang; Adedotun Ogunbajo; Keith J Horvath; Cathy J Reback; Jill Blumenthal; David J Moore; Risa P Flynn; Robert K Bolan; Katya C Corado; Sheldon R Morris Journal: AIDS Behav Date: 2022-09-02
Authors: Denton Callander; Byoungjun Kim; Micah Domingo; Loni Philip Tabb; Asa Radix; Liadh Timmins; Amir Baradaran; Michael B Clark; Dustin T Duncan Journal: Transgend Health Date: 2022-08-01
Authors: Joseph G Rosen; Ju Nyeong Park; Kristin E Schneider; Rebecca Hamilton White; S Wilson Beckham; Jennifer L Glick; Katherine H A Footer; Susan G Sherman Journal: AIDS Behav Date: 2022-04-01
Authors: Karine Dubé; John Kanazawa; Chadwick Campbell; Cheriko A Boone; Allysha C Maragh-Bass; Danielle M Campbell; Moisés Agosto-Rosario; Jamila K Stockman; Dázon Dixon Diallo; Tonia Poteat; Mallory Johnson; Parya Saberi; John A Sauceda Journal: AIDS Res Hum Retroviruses Date: 2021-05-31 Impact factor: 2.205
Authors: Scott D Rhodes; Lisa M Kuhns; Jasmine Alexander; Jorge Alonzo; Patricia A Bessler; Cari Courtenay-Quirk; Damian J Denson; Kaiji Evans; Carla A Galindo; Robert Garofalo; Deborah J Gelaude; Anna L Hotton; Amy K Johnson; Lilli Mann-Jackson; Abigail Muldoon; Reyna Ortiz; Josie Lynne Paul; Judy Perloff; Kevin Pleasant; Beth A Reboussin; Lucero Refugio Aviles; Eunyoung Y Song; Amanda E Tanner; Scott Trent Journal: AIDS Educ Prev Date: 2021-08